Patients' views and experiences on the supported self-management/patient-initiated follow up pathway for breast cancer
- PMID: 37889343
- PMCID: PMC10611591
- DOI: 10.1007/s00520-023-08115-5
Patients' views and experiences on the supported self-management/patient-initiated follow up pathway for breast cancer
Abstract
Purpose: To explore patients' expectations and experience of Supportive Self-Management (SSM)/ Patient Initiated Follow Up (PIFU) following breast cancer treatments over a 12-month period.
Methods: In total, 32/110 (29%) patient participants in the PRAGMATIC (Patients' experiences of a suppoRted self-manAGeMent pAThway In breast Cancer) study were interviewed at baseline, 3, 6, 9 and 12 months. Interviews in this sub-study used a mix-methods approach to explore understanding of the pathway, confidence in self-management, triggers to seek help and/or re-engage with the clinical breast team and impact of the COVID-19 pandemic. Responses to pre-assigned categories were summarised as counts/ percentages and collated in tabular or graphic format. Free responses were recorded verbatim and reviewed using framework analysis.
Results: Participants regarded the SSM/PIFU pathway as a way to save time and money for them and the National Health Service (NHS) (14/32; 44%) and as a means of assuming responsibility for their own follow-up (18/32; 56%). Most maintained (very/somewhat) confidence in managing their BC follow-up care (baseline 31/32, 97%; 12 months 29/31, 93%). During the year, 19% (5/26) stopped endocrine therapy altogether because of side effects. Qualitative analysis revealed general satisfaction with SSM/PIFU and described the breast care nurses as reassuring and empathic. However, there was a lingering anxiety about identifying signs and symptoms correctly, particularly for those with screen-detected cancers. There was also uncertainty about who to contact for psychological support. The COVID-19 pandemic discouraged some participants from contacting the helpline as they did not want to overburden the NHS.
Conclusions: The results show that during the first year on the SSM/PIFU pathway, most patients felt confident managing their own care. Clinical teams should benefit from understanding patients' expectations and experiences and potentially modify the service for men with BC and/or those with screen-detected breast cancers.
Keywords: Breast cancer; COVID-19; Patient-initiated follow-up; Semi-structured interviews; Supported self-management.
© 2023. The Author(s).
Conflict of interest statement
Author VJ was awarded grant funding from SSCA to conduct the study. Author MT is the Co Clinical Lead for Personalised Care and Support at SSCA; Authors DB and CZ are joint Chairs of the Breast High Priority Pathway Group at the SSCA; Author FM was the Medical Director for the SSCA, and author SB is employed by the SSCA. All other authors have no relevant financial or non-financial interests to disclose.
Figures
References
-
- International Agency for Research on Cancer. World cancer report: cancer research for cancer prevention. Accessed March 13th 2023 https://www.iarc.who.int/cancer-type/breast-cancer/
-
- Cancer Research UK. Breast cancer survival statistics. Accessed March 13th 2023 https://www.cancerresearchuk.org/health-professional/cancer-statistics/s...
-
- NHS long term plan (https://www.longtermplan.nhs.uk/). Accessed Jan 9th 2023
-
- NHS England: personalised care and improving quality of life outcomes (https://www.england.nhs.uk/cancer/living/#follow-up-care) accessed March 12th 2023
-
- Taylor SJC, Pinnock H, Epiphaniou E et al (2014) A rapid synthesis of the evidence on interventions supporting self-management for people with long term conditions (PRISMS Practical systematic review of self-management support for long-term conditions). Health Serv Deliv Res 2(53) - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
